These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7878810)

  • 21. Pretransplant serum IgG-anti-F(ab')2gamma activity and kidney graft outcome: comparison of results obtained at two centers.
    Süsal C; Groth J; Oberg HH; Terness P; May G; Staehler G; Opelz G
    Transpl Int; 1992; 5 Suppl 1():S625-6. PubMed ID: 14621892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin G-positive in B-cell cross-match decreases kidney allograft survival.
    Fagundes I; Michelon T; Schoroeder R; Fernandes S; Sporleder H; Canabarro R; Rodrigues H; Petry M; Zanenga D; Silveira J; Montagner J; Bortolotto A; Keitel E; Santos A; Garcia V; Neumann J
    Transplant Proc; 2005; 37(6):2753-4. PubMed ID: 16182801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA.
    Martín-Pagola A; Ortiz-Paranza L; Bilbao JR; de Nanclares GP; Estevez EP; Castaño L; Vitoria JC
    Autoimmunity; 2007 Mar; 40(2):117-21. PubMed ID: 17364503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretransplant calcium levels have no predictive value for delayed graft function, long-term graft function, cardiovascular events, or graft and patient survival in renal transplantation.
    Krüger B; Schnitzbauer AA; Böger CA; Hoffmann U; Banas B; Farkas S; Schlitt HJ; Obed A; Krämer BK
    Transplant Proc; 2006 Apr; 38(3):697-700. PubMed ID: 16647448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer.
    Süsal C; Maier H; Lorenz K; Opelz G
    Int J Cancer; 1994 Apr; 57(1):47-50. PubMed ID: 8150540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preexisting antibodies: the clinical relevance of auto-B-lymphocyte antibody and positive B-cell crossmatch.
    Mongkolsuk T; Chiewsilp P; Sujirachato K; Sumethkul V; Jirasiritham S; Chalermsanyakorn P; Danviriyasup K
    Transplant Proc; 1996 Jun; 28(3):1215-6. PubMed ID: 8658631
    [No Abstract]   [Full Text] [Related]  

  • 27. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
    Shield CF
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
    [No Abstract]   [Full Text] [Related]  

  • 28. Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival.
    Kaminska D; Bernat B; Mazanowska O; Krasnowski R; Polak W; Patrzalek D; Kochman A; Klinger M
    Transplant Proc; 2006; 38(1):59-61. PubMed ID: 16504664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):121-3. PubMed ID: 19249493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of anti-IgG autoantibodies in kidney transplantation.
    Süsal C; Guo ZG; Terness P; Opelz G
    Immunol Lett; 1990 Nov; 26(2):121-5. PubMed ID: 2269482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine.
    Sutherland DE; Moudry-Munns KC; Gruessner A
    Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866
    [No Abstract]   [Full Text] [Related]  

  • 33. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels.
    Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD
    Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C
    Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685
    [No Abstract]   [Full Text] [Related]  

  • 36. Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups?
    Cecka JM; Gjertson D; Terasaki PI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):548-9. PubMed ID: 8438408
    [No Abstract]   [Full Text] [Related]  

  • 37. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 38. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of amino acid residue matching for HLA molecule in graft survival in renal transplantation.
    Ogahara S; Naito S; Noda R; Michinaga I; Murata T
    Transplant Proc; 1996 Jun; 28(3):1260-1. PubMed ID: 8658650
    [No Abstract]   [Full Text] [Related]  

  • 40. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation.
    Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L
    Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.